Overview
Obstructive sleep apnea (OSA) is highly prevalent in the general population and is associated with multiple adverse cardiovascular consequences.
Screening for OSA is recommended in those with typical symptoms, such as daytime sleepiness, loud snoring, or abrupt awakenings with gasping or choking. Patients admitted to the general medical wards with these symptoms will be evaluated for the possibility of having OSA.
Description
Obstructive sleep apnea (OSA) is a disease that is highly prevalent in all communities and is associated with adverse cardiovascular events.
Screening for OSA is recommended in men and women who have the typical symptoms, including snoring, daytime sleepiness, or abrupt awakenings with choking or gasping.
OSA screening is also recommended for those with resistant hypertension, bradyarrhythmias, and atrial fibrillation.
Heart failure patients should also be screened for OSA. It is very important to increase the use of OSA screening especially in patients admitted to the medical floor in tertiary care hospitals. No study has evaluated this topic in the Middle East in the past.
Eligibility
Inclusion Criteria:
- Willing to sign an informed consent
- Patient is admitted to the medical ward in a tertiary hospital
Exclusion Criteria:
- Patients known to have obstructive sleep apnea.
- Patients younger than 18 years of age